Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A) Report in English with a Dutch summary (KCE reports 45A)
6 Screening for Colorectal Cancer KCE reports vol.45 ESR Age standardised incidence rate, using the European Standard Population (n/100.000 person years) EU European Union FAP Familial Adenomatous Polyposis FDR First Degree Relative FIT Faecal Immunochemic Test = iFOBT FNR False Negative Rate FOBT Faecal Occult Blood Test FPR False Positive Rate FS Flexible Sigmoidoscopy GCP Good Clinical Practice gFOBT Guaiac Faecal Occult Blood Test GP General Practitioner HAS Haute Autorité de Santé HC/PR Health Care/Prevention Recommendations HCR Health Care Recommendation HMO Health Maintenance Organization HNPCC Hereditary Nonpolyposis Colorectal Cancer HTA Health Technology Assessment IBD Inflammatory Bowel Disease ICER Incremental Cost-Effectiveness Ratio ICSI Institute of Clinical Systems Improvement ICT ImmunoChemical Test = iFOBT iFOBT Immunochemical Faecal Occult Blood Test IKC Integraal Kanker Centrum (Netherlands) ITS Intention To Screen ITT Intention To Treat JNCI Journal of the National Cancer Institute M2 - PK M2 Pyruvate kinase MOH Ministry of Health (NZ) MRI Magnetic Resonance Imaging MSI Microsatellite instability NCCN National Comprehensive Cancer Network NCI National Cancer Institute (USA) NGC National Guidelines Clearinghouse NHC National Health Committee (NZ) NHS National Health Service (UK) NHS EED NHS Economic Evaluation database NNS Number Needed to Screen NPV Negative Predictive Value NSU National Screening Unit (NZ) NZ New Zealand NZD New Zealand dollars NZGG New Zealand Guidelines Group NZHTA New Zealand Health Technology Assessment OECD Organisation for Economic Cooperation and Development oFOBT office-based FOBT OMGE Organisation Mondiale de Gastro-Entérologie OR Odds Ratio p.a. per annum PCR Polymerase Chain Reaction PPV Positive Predictive Value
KCE reports vol.45 Screening for Colorectal Cancer 7 QALY Quality Adjusted Life Years RCT Randomized Controlled Trial RR Relative Risk RRR Relative Risk Reduction SD Standard Deviation SDR Second Degree Relative Se Sensitivity SEER Surveillance, Epidemiology and End Results registry SG Screening Group SIGN Scottish Intercollegiate Guidelines Network SFED Société Française d'Endoscopie Digestive Sp Specificity TCE Total Colon Evaluation TCR Two Close Relatives TDR Third Degree Relative TPR True Positive Rate UICC Union Internationale Contre le Cancer - International Union Againt Cancer UK United Kingdom UMHS University of Michigan Health System US United States of America USD United States dollars USPSTF U.S. Preventive Services Task Force VA Veterans Affairs WGO World Gastroenterlogy Organisation WHO World Health Organization WSR Age standardised incidence rate, using the World Standard Population (n/100.000 person years)
- Page 1 and 2: Health Technology Assessment Colore
- Page 3 and 4: Health Technology Assessment Colore
- Page 5 and 6: KCE reports vol.45A Colorectale Kan
- Page 7 and 8: KCE reports vol.45A Colorectale Kan
- Page 9: KCE reports vol.45A Colorectale Kan
- Page 12 and 13: 2 Screening for Colorectal Cancer K
- Page 14 and 15: 4 Screening for Colorectal Cancer K
- Page 18 and 19: 8 Screening for Colorectal Cancer K
- Page 20 and 21: 10 Screening for Colorectal Cancer
- Page 22 and 23: 12 Screening for Colorectal Cancer
- Page 24 and 25: 14 Screening for Colorectal Cancer
- Page 26 and 27: 16 Screening for Colorectal Cancer
- Page 28 and 29: 18 Screening for Colorectal Cancer
- Page 30 and 31: 20 Screening for Colorectal Cancer
- Page 32 and 33: 22 Screening for Colorectal Cancer
- Page 34 and 35: 24 Screening for Colorectal Cancer
- Page 36 and 37: 26 Screening for Colorectal Cancer
- Page 38 and 39: 28 Screening for Colorectal Cancer
- Page 40 and 41: 30 Screening for Colorectal Cancer
- Page 42 and 43: 32 Screening for Colorectal Cancer
- Page 44 and 45: 34 Screening for Colorectal Cancer
- Page 46 and 47: 36 Screening for Colorectal Cancer
- Page 48 and 49: 38 Screening for Colorectal Cancer
- Page 50 and 51: 40 Screening for Colorectal Cancer
- Page 52 and 53: 42 Screening for Colorectal Cancer
- Page 54 and 55: 44 Screening for Colorectal Cancer
- Page 56 and 57: 46 Screening for Colorectal Cancer
- Page 58 and 59: 48 Screening for Colorectal Cancer
- Page 60 and 61: 50 Screening for Colorectal Cancer
- Page 62 and 63: 52 Screening for Colorectal Cancer
- Page 64 and 65: 54 Screening for Colorectal Cancer
<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer 7<br />
QALY Quality Adjusted Life Years<br />
RCT Randomized Controlled Trial<br />
RR Relative Risk<br />
RRR Relative Risk Reduction<br />
SD Standard Deviation<br />
SDR Second Degree Relative<br />
Se Sensitivity<br />
SEER Surveillance, Epidemiology and End Results registry<br />
SG Screen<strong>in</strong>g Group<br />
SIGN Scottish Intercollegiate Guidel<strong>in</strong>es Network<br />
SFED Société Française d'Endoscopie Digestive<br />
Sp Specificity<br />
TCE Total Colon Evaluation<br />
TCR Two Close Relatives<br />
TDR Third Degree Relative<br />
TPR True Positive Rate<br />
UICC Union Internationale Contre le Cancer - International Union Aga<strong>in</strong>t Cancer<br />
UK United K<strong>in</strong>gdom<br />
UMHS University of Michigan Health System<br />
US United States of America<br />
USD United States dollars<br />
USPSTF U.S. Preventive Services Task Force<br />
VA Veterans Affairs<br />
WGO World Gastroenterlogy Organisation<br />
WHO World Health Organization<br />
WSR<br />
Age standardised <strong>in</strong>cidence rate, us<strong>in</strong>g the World Standard Population<br />
(n/100.000 person years)
Change language